A innovative treatment
Introducition of a incredible new methods full of hope
An opportunity for Antonella
Antonella was recently selected to receive treatment at NeuroCytonix in Mexico, a program known for its innovative approach to neurological rehabilitation. After reviewing her medical history, progress, and potential for improvement, the team determined that she is an excellent candidate for their specialized therapy. This opportunity gives Antonella access to advanced technology and expert care designed to support her development in ways traditional therapies cannot. Being chosen is a tremendous blessing — one that brings new hope, new possibilities, and a brighter path forward for her journey.
The Cytotron
The Cytotron is a non‑invasive regenerative medicine device created by physicist Rajah Vija Kumar. It uses magnetic‑resonance–based technology and gentle, modulated radio‑frequency waves to support tissue regeneration and help reconnect damaged neurons. This therapy is being explored for conditions like cerebral palsy and other degenerative challenges, with the goal of improving mobility, function, and overall quality of life.
For Antonella, the Cytotron represents one more path filled with hope—another opportunity to support her development, strengthen her progress, and give her the best possible chance to thrive.
"NeuroCytonix" Mexico
NeuroCytonix Mexico was established in 2018 and operates a state-of-the-art clinical research center in compliance with the International Council for Harmonisation (ICH) E6R3 guidelines for "Good Clinical Practice."
Located in Monterrey, Mexico, our clinical research center provides access to investigational protocols we are developing for various neurological conditions. Our current protocols focus on cerebral palsy, autism, stroke, traumatic brain injury, and vascular dementia.
How it works
At NeuroCytonix, their protocols are focused on enhancing the natural process of nerve cell repair to restore function and relieve symptoms for people with neurological conditions.
The protocol uses a combination of instantaneous magnetic fields and radiofrequency signals delivered to damaged areas of the brain by our medical technology. Because of the nature of our regenerative medicine approach, research into the protocol’s impact on people with neurological disorders is ongoing. These protocols include precisely calculated doses of electromagnetic signals, delivered in pulses to damaged cells. Using low-energy radiofrequency, we target signals directly at the cells. Functional neurogenesis stimulation is the promotion of new functional neural pathways.